How best is to discontinue postmenopausal hormone therapy: immediate or tapered?

Maturitas. 2007 Jan 20;56(1):78-83. doi: 10.1016/j.maturitas.2006.06.006. Epub 2006 Oct 13.

Abstract

Background: To evaluate the differences between the immediate and tapered cessation protocols of hormone therapy in terms of recurrence of menopausal symptoms.

Materials and methods: In this prospective, randomized clinical study 70 consecutive patients in whom hormone therapy was no longer preferred were recruited from the menopause clinic of a university hospital and rank randomized into two groups. In group 1 (n=35) hormone therapy was immediately discontinued and in group 2 (n=35) the medication was tapered. Every patient was questioned about vasomotor symptoms before the initiation of hormone therapy at the first visit, and then revisited at the end of 2 and 4 weeks.

Results: We did not find any statistically significant difference between two protocols in terms of symptom severity and frequency at the end of 2 and 4 weeks of discontinuation. Although statistically insignificant, the symptoms tended to recur in fewer patients and in a less severe form in both groups when compared with their pretreatment status.

Conclusions: Tapering or immediate discontinuing of hormone therapy did not affect the recurrence rate and severity of menopausal symptoms at the end of 4 weeks.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Drug Administration Schedule
  • Estrogen Replacement Therapy / adverse effects
  • Estrogen Replacement Therapy / methods*
  • Estrogens / administration & dosage*
  • Female
  • Hot Flashes / drug therapy*
  • Humans
  • Middle Aged
  • Postmenopause / drug effects*
  • Progestins / administration & dosage*
  • Prospective Studies
  • Recurrence
  • Severity of Illness Index

Substances

  • Estrogens
  • Progestins